Innovent Partners
Innovent Partners
Current Locations:Home > Innovent Partners

EpimAb Biotherapeutics is a privately owned biopharmaceutical R&D company based in Shanghai with a proprietary unique and efficient technology called FIT-Ig® (Fabs-In-Tandem Immunoglobulin) to generate bispecific molecules with antibody-like properties. With this platform EpimAb is creating a pipeline of novel bispecific antibody therapeutics focused around immuno-oncology and other areas of high value to patients.


Copyright © 2011- Innovent Biologics, Inc.
Powered by RuiXi